trending Market Intelligence /marketintelligence/en/news-insights/trending/OQgsG55f1OaDXPRItJ5Byg2 content esgSubNav
In This List

ReShape Lifesciences to be delisted from Nasdaq

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


ReShape Lifesciences to be delisted from Nasdaq

ReShape Lifesciences Inc. said Nasdaq has determined to delist the company's shares from the stock exchange Dec. 31.

The decision is based on ReShape Lifesciences' failure to regain compliance with the exchange's $1 minimum bid price requirement.

The San Clemente, Calif.-based medical device company also failed to inform the exchange of its intent to list additional shares, another listing requirement.

ReShape Lifesciences stocks will now trade on the OTC Markets under the symbol RSLS.